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From the foregoing papers it is abundantly clear that the adolescent provides 
a veritable Pandora’s Box of clinical problems, including various degrees of fail- 
ure of fusion of the miillerian ducts; upsets of the delicate balance of a hormonal 
relationship and the far reaching effects of these inter-relationships; the problems 
of chromosomal aberrancies; prediliction of the ovary to tumor formation; the 
disturbing effects of systemic disease, and the disrupting influences of the psyche 
and environment, of which amenorrhea is but one symptom. 
When one realizes how much can go wrong the wonder of it all is how so 
many survive at all. Because of the tremendous psychologic impact of the onset 
of menstruation, it is now well recognized that the modern mother tends to pre- 
pare her daughter for the event. All too often, if the menarche does not appear 
at the time that the mother’s experience leads her to believe it should, the mother 
will become concerned and bring the problem to the attention of the physician. 
In most instances, the astute gynecologist will easily see the sources of concern 
and can placate both the mother and patient. However, it is essential to realize 
that the late onset of menses, e.g. 16 years and over, may well be indicative of 
some endocrine dysfunction or delayed development of the reproductive system, 
and one purpose of this investigation is to discover to what extent it will later 
influence the fertility potential. 
Environment, physical condition and socioeconomic status also affect the age 
of menarche. Sexual stimulation may bring about the earlier menarche, as seen 
in some primitive tribes where social customs do not frown upon promiscuity. 
Anemia and other chronic disease, as well as malnutrition and psychic stress, all 
have an inhibiting effect and tend to produce a later menarche. Delayed menarche 
is a term applied when menses have not started by the age of 16. When menses 
have not appeared by the age of 17 this should be considered as primary amenor- 
rhea. Delay may be due to physiologic, anatomic, pathological, or constitutional 
causes. It should also be realized that poor general health and inadequate nutri- 
tion, hypothyroidism, detrimental environmental conditions, obesity and psychic 
disturbances can all cause a delay in the menarche. Thus, investigation should 
not be delayed beyond the age of 16. 
The problem of adolescent amenorrhea is, therefore, significant not only 
because of its incidence, but because it has many etiologic origins, several of 
which, at the moment, defy correction, and most of which will have profound 
impact on the young female’s everyday life and later reproductive potentialities. 
Furthermore, there is no unanimity of opinion among the clinicians as to the 
definition of primary amenorrhea, what constitutes adequate investigation, and 
what therapeutic measures should or should not be instituted. 
For these reasons, a prospective and ongoing program was instituted in 1960 
to study the problem of both primary and secondary amenorrhea. This material’ 
has now been under study for some six years and this presentation must only be 
considered as an interim report. It is important to note that the cases here 
are unselected and that this very fact has considerable significance when 
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evaluating relative frequencies of any particular condition. At the time the study 
began, we defined primary amenorrhea as any patient who had never menstru- 
ated and secondary amenorrhea as one who had missed at least four periods. The 
total number of cases presented here number 370, of which 304 are secondary 
and 66 are primary, and they are further divided into age groups 13 to 20 and 
21 to 35 years of age. 
Beside the personal and family history, a physical and pelvic examination plus 
endoscopic evaluation was done. Wherever possible, x-ray of the skull, matura- 
tion indices, nuclear sex chromatin, protein bound iodine (PBI) , follicular stimu- 
lating hormone (FSH), estrogens, and 17-ketosteroids were done, and either 
culdoscopy, celioscopy, gyoecography or laparotomy was performed wherever 
possible. In 60 of the 66 cases of primary amenorrhea the ovary was visualized. 
Selected cases had karyotypes done and other appropriate special studies. 
Results 
The cases of secondary amenorrhea show an age distribution very much in 
parallel with MacArthur’s report? with a mean age of onset of the menarche at 
13.2 years with limits of 8 to 21; almost all had started menses by the age of 17. 
(TABLE 1 ) . 
TABLE 2 summarizes the cases of primary amenorrhea. The first observation 
is that 17 of 66, or 25 percent of etiologic factors in primary amenorrhea are 
chromosomal in origin. If one were then to remove the cases of primary amenor- 
rhea that are readily treated due to some systematic disease, e.g. thyroid, adrenal, 
systemic disease, pregnancy or delayed menses, the incidence of chromosomal 
defects rises to 46 percent, which parallels the original suggestion of Jacobs3 and 
Phillip! who first indicated the high incidence of chromosomal defects in pri- 
mary amenorrhea. 
Nine of 66 cases were due to developmental defects, e.g. vaginal agenesis. It 
is interesting to observe that three of the cases were not recognized until after 
the age of 20, indicating failure of pelvic examination at the time of clinical 
evaluation and that the most propitious time for reconstruction of the vagina 
had already passed. It is of interest to note too that two cases with absence of 
the vagina had uteri with functioning ovaries and the presence of endometriosis. 
It will be noted that of the seven cases listed as Turner’s Syndrome, only five 
showed the XO complement and two were XO/XY mosaics, yet all had the 
streak ovary. In the ovarian deficiency states, it is interesting to note that varying 
developmental stages of the ovary were seen from the streak through the some- 
what larger ovary, but which was afollicular compared with the normal-sized 
ovary which was multi-follicular and even with four cases which were called 
polycystic ovary and more closely resembled the ovary of Stein and Leventhal. 
Of more significance is the fact that only 20 percent of these cases of primary 
amenorrhea to date could be made to menstruate, and 29 of the 66 will never 
menstruate either because of chromosomal or developmental errors. The signifi- 
cance of this for future reproduction is most important. A glance at  TABLE 2 
where the secondary amenorrheas are reviewed is also illuminating. There are 
42 cases of pituitary failure, of which only five recovered following therapy. 
There are also 17 cases of secondary ovarian failure. This latter group is ex- 
tremely interesting and has been the subject of considerable discussion by Keetel 
and B r a d b ~ r y . ~  They have termed this condition “premature ovarian failure.” 
Although some of these cases had actually had children before cessation of their 
menses, others had never had normal periods, with the exception of more or less 
regular menstrual flows for three to four years prior to developing permanent 




Etiology A 2  13-20 Y C ~  A p  20-335 ye- 
Probably hypothalamic 
Psychoses & P. disorders 
Obesity 
Pituitary tumor 1 6 (2) 
Pituitary failure 15 27 ( 5 )  
Ovarian tumor 2 (2) - 
Polycystic disease 11 ( 5 )  31 (27) 





Endometrial - 11 (4) 
Systemic disease 12 (4) 7 (1) 
Unclassified 24 (4) 32 (5) 
108** 196* 
120 cases treated with 64 or 50% recovery. 




EUoIow Age 13-20 years Age 20-35 yean 
Personality disorder 
Pituitary tumor 







Ovarian deficiency (streak) 3 I 
Polycystic disease 1 3 (3) 
Turner's syndrome 1 6 
Thyroid (hypo) 1 (1) 1 (1) 
Adrenal (hyper) 2 (1) 1 (1) 
~~ 
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ovarian failure. I feel sure some of these latter cases must constitute a degree of 
ovarian hypoplasia capable of some menstruation and which have then prema- 
turely failed leading to a hypergonadotropic state. As I have observed before,' 
it is interesting to observe that the incidence of thyroid disturbance as a cause 
of either primary or secondary amenorrhea does not exceed 3.5 percent and con- 
sequently caution the injudicious use of thyroid as a panacea for amenorrhea. 
Of the 120 cases treated in this group, only 64 or 50 percent recovered. 
Now, it is obvious that primary or even secondary adolescent amenorrhea is 
a serious prognosticator for the future fertility of a young female. If one were 
to study some of the demographic reportss on the relationship of onset of the 
menarche and later fertility, one is impressed by the relative decrease in fertility 
and increase in sterility as the age of onset of menarche goes up. Makuda' reports 
on 370 Japanese females who were studied, where the sterility index of those 
females who started menstruating at the age of 12 was approximately 2; in those 
who started at the age of 14 the index was 6, and in those who started at the age 
of 18 the index was 20. Clearly then, primary amenorrhea, secondary amenor- 
rhea, and even delayed menses are all indicators of future reproductive problems 
and in that order of severity. 
Certainly chromosomal defects and ovarian deficiency states seem to play the 
major role in adolescent amenorrhea, conditions with which the clinician and 
practitioner who sees these young females must become familiar. For this reason, 
a method for classifying these problems is presented based on the original classi- 
fication of Kinch and his co-workers: which seems to offer a reasonably logical 
approach (TABLE 3). In this classification, it is important for the clinician to 
examine the patient thoroughly with special reference to the body formation, the 
nuclear chromatin pattern, and where feasible a karyotype supplemented by 
gonadotrophin, estrogen and 17-ketosteroid estimation, and ideally supported 
TABLB 3 
Body formation Extragenital Turner Turner with Eunochoid 0 
(x-rays bones) anomalies other patterns features 
pattern XO/XY mosaic 
Nuclear chromatin XY (46) XO (45) Variable X X ( 4 6 )  XX(46) 
Gonadotrophin 4 6 6 6 Variable 
Estrogen v v v 9 Variable 
Culdoscopy Streak Streak Streak or Afollicular Small with 
Pnueumohysterogram ovary larger follicular normal 
Laparotomy Complement 
v. Polycystic ovary 
VI. 2 O  Ovarian failure 
(a) Hypothalamo-pituitary axis 
(b) Thyroid 
(c) Adrenal 
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by culdoscopy, pneumohysterogram, or laparotomy where possible. In order to 
describe the size and development of the ovary, these are then classified into six 
major groups: Group I would be pure gonadal agenesis with a male XY (46) 
type chromosome and hypergonadotrophic state and streak ovary; Group I1 (a)  
would be the partial gonadal dysgenesis of Turner with the typical Turner body 
formation and XO (45) karyotype and streak ovary; Group I1 (b) would include 
the body configuration of Turner, but the XO/XY mosaic as a variable; Group 
I11 would be the XX (46) type female of the tall stature who would be hyper- 
gonadotrophic with ovarian agenesis. In these instances the ovary might be of 
the streak type or occasionally somewhat larger, with or without follicular cysts.9 
On occasion these follicular cysts are present even in the absence of a hyper- 
gonadotrophic state and it makes for interesting speculation as to their origin. 
Govan and Mukherjee,lo Stange," and others have reported this type of ovary 
with follicular cysts in newborn infants born of mothers with severe preeclamptic 
toxemia and raise the question as to whether this might not be due to excessive 
maternal pituitary stimulation of the fetal ovary. Group IV is the girl with typical 
female body formation, XX (46) nuclear pattern, with a small ovary but of 
normal complement. Group V would be the polycystic ovary, and Group VI 
would be secondary ovarian failure due to other causes, e.g. adrenal hyperplasia 
or hypothyroidism. On the extreme left hand side of this table would be the 
ovotestis or testicular feminizing ovary with masculinization. 
Conclusion 
In conclusion, it now remains for me only to state the obvious: 
(1) As by far the greatest number of contemporary young females have 
started their menses by the age of 16 or 17, a delay beyond this age should be 
considered as primary (or adolescent) amenorrhea and, therefore, a full evalua- 
tion at this time prior to institution of therapy is in order. This applies equally 
well to secondary (adolescent) amenorrhea of longer than six months duration. 
Mention is made of evaluation prior to therapy as a warning to those who so 
liberally give estrogen containing hormones, and to them I would advise rather 
considerable restraint to avoid vigorous over-treatment with endocrine therapy, 
especially estrogen, which will accelerate epiphyseal closure and is clearly un- 
warranted. The pubescent organism is best given every opportunity to evolve 
spontaneously through the activation of normal developmental mechanisms. 
(2) Inasmuch as elaborate and costly studies may be required to elucidate 
the cause of amenorrhea, it is important to extract all information from history, 
physical and pelvic examination, eating and recreation habits, emotional adjust- 
ment, and environment. 
(3) Early diagnosis is important to permit correction of reversible etiologic 
factors, to permit vaginal reconstruction at a propitious time, and permit those 
unfortunate females who will be permanently sterile the privilege of adjusting 
their lives accordingly. 
(4) Evidence suggests that primary or secondary adolescent amenorrhea is 
associated with a definite decrease in fertility potential. 
( 5 )  Because almost one-third of adolescent primary amenorrheas are due to 
chromosomal defects, nuclear sex chromatin and karyotypes, culdoscopy, and 
laparotomy with gonadal biopsy where possible is essential. 
(6) Finally, a useful working classification is presented as a guide in approach 
to such ovarian deficiencies. 
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